Abemaciclib: prices and alternatives
Abemaciclib is a CDK4/6 inhibitor indicated for HR-positive, HER2-negative breast cancer: (1) as adjuvant therapy with endocrine therapy in node-positive early breast cancer at high recurrence risk; (2) combined with an aromatase inhibitor as initial therapy for advanced or metastatic disease; (3) combined with…
4 products with this active ingredient from 1 manufacturer. Official price: 21774 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.



